Synthetic Design Lab
United States
- San Francisco Bay Area
- 24/04/2025
- Unknown
- $20,000,000
A next-generation ADC company developing a novel SYNTHBODY therapeutic platform against a range of cancer types
- Industry Biotechnology Research
- Website https://www.syntheticdesignlab.com/
- LinkedIn https://www.linkedin.com/company/synthetic-design-lab-inc/
Related People
Daniel Chen, M.D. Ph.D.Founder
United States -
Burlingame, California
Author of The Cancer-Immunity Cycle (Immunity 2013) and the Cancer-Immune Set Point (Nature 2017) with Ira Mellman.
A pioneer in the field of Cancer Immunotherapy, emergence of PD-L1/PD-1 inhibitors and next generation therapies. Focused on the future of medicine and what's possible at the intersection between engineering, science and medicine.
Experienced drug developer (from pre-clinical through Phase I-IV), entrepreneur, executive- strong communicator and strategic leader with expertise in Oncology, Immunology, Large Molecule Engineering, Virology, Filings, Biomarkers and Building/Leading Organizations.
WealthAi | $1,000,000 | (Jan 30, 2026)
Checkbox | $23,000,000 | (Jan 30, 2026)
PaleBlueDot AI | $150,000,000 | (Jan 30, 2026)
Mesh Security | $12,000,000 | (Jan 30, 2026)
Datalinx AI | $4,200,000 | (Jan 30, 2026)
Ressio Software | Undisclosed Amount | (Jan 30, 2026)
Co-reactive | $7,754,157 | (Jan 30, 2026)
Arkero | $6,000,000 | (Jan 30, 2026)
Redwood Materials | $425,000,000 | (Jan 30, 2026)
Twogee Biotech | $2,575,886 | (Jan 30, 2026)
Levellr | $2,500,000 | (Jan 30, 2026)
Indigo(1) | $50,000,000 | (Jan 30, 2026)
heyData | $16,500,000 | (Jan 30, 2026)